Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vilvam Tablet is a classical Siddha herbal formulation manufactured by SKM Siddha & Ayurveda Company India Ltd. It is specifically indicated for the management of diabetes mellitus (Madhumegam) and hyperglycemia. Each 500 mg tablet is composed of a combination of five primary herbal ingredients, each comprising 20% of the formulation: *Eugenia jambolana* (Jamun), *Aegle marmelos* (Bilva/Bael), *Azadirachta indica* (Neem), *Trigonella foenum-graecum* (Fenugreek), and *Gymnema sylvestre*. These ingredients are processed in a variety of herbal decoctions (kasayams) including *Cassia auriculata*, *Andrographis paniculata*, *Mangifera indica*, and *Pterocarpus marsupium*. The formulation works through its hypoglycemic properties, reducing oxidative stress on the pancreas and increasing systemic antioxidant levels to assist in glycemic control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vilvam Tablet.